Abha Biotechnology Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 09-12-2024
- Paid Up Capital ₹ 0.10 M
as on 09-12-2024
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -85.85%
(FY 2023)
- Profit -18053.47%
(FY 2023)
- Ebitda -1126.83%
(FY 2023)
- Net Worth -485.79%
(FY 2023)
- Total Assets 2.19%
(FY 2023)
About Abha Biotechnology
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rakesh Shahi and Mohmad Ahmed serve as directors at the Company.
- CIN/LLPIN
U74999UP2018PTC102690
- Company No.
102690
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Apr 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Abha Biotechnology Private Limited offer?
Abha Biotechnology Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops, Flavours & Aromatics, Food Enzymes, Common Disease Medicines, Pharmaceutical Medicine, Digestive System Drugs & Medicines, Digestive Drugs, Nutritional Supplements, Dietary Supplements.
Who are the key members and board of directors at Abha Biotechnology?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohmad Ahmed  | Director | 02-Apr-2018 | Current |
| Rakesh Shahi | Director | 02-Apr-2018 | Current |
Financial Performance of Abha Biotechnology.
Abha Biotechnology Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 85.85% decrease. The company also saw a substantial fall in profitability, with a 18053.47% decrease in profit. The company's net worth observed a substantial decline by a decrease of 485.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Abha Biotechnology?
Unlock access to Abha Biotechnology's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Lifescience Intellipedia Private LimitedActive 8 years 8 monthsRakesh Shahi and Mohmad Ahmed are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Abha Biotechnology?
Unlock and access historical data on people associated with Abha Biotechnology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Abha Biotechnology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abha Biotechnology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
